CD274 and neoplasm: The prevalence of biomarker-positive populations at baseline stratified by percentage of stromal tumor-infiltrating lymphocytes (sTILs) at various cutoffs, compared with those by PD-L1 SP142 at 1% IC, is shown in Supplementary Fig. 7.